Monitoring plasma nucleosome concentrations to measure disease response and progression in dogs with hematopoietic malignancies.

Heather Wilson-RoblesEmma WarryTasha MillerJill JarvisMatthew MatsushitaPamela MillerMarielle HerzogJean-Valery TuratsinzeTheresa K KellyS Thomas ButeraGaetan Michel

Published in: PloS one (2023)

Plasma nucleosome concentrations can be a useful tool for treatment monitoring and disease progression in dogs with hematopoietic malignancies.

Keyphrases

bone marrow
combination therapy
replacement therapy